PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
103.69%
Net income growth 1.25-1.5x CRON.TO's 87.84%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
51.17%
D&A growth well above CRON.TO's 35.25%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
91.02%
Some yoy growth while CRON.TO is negative at -10.71%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-33.74%
Negative yoy SBC while CRON.TO is 4670.27%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-45.01%
Both reduce yoy usage, with CRON.TO at -245.48%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
26.09%
AR growth of 26.09% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
92.65%
Inventory shrinking or stable vs. CRON.TO's 268.53%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
-98.99%
Both reduce yoy usage, with CRON.TO at -1751.02%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-71.30%
Both negative yoy, with CRON.TO at -167.78%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-1.79%
Both yoy CFO lines are negative, with CRON.TO at -157.20%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
20.61%
Some CapEx rise while CRON.TO is negative at -1003.72%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
637.71%
We have some outflow growth while CRON.TO is negative at -119935.37%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
21.63%
We have mild expansions while CRON.TO is negative at -88016.71%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
14439.79%
Stock issuance far above CRON.TO's 143.97%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.